Max_Regards
Oct 29, 5:46 PM
$LENZ hey, at least things are changing 🤷🏻♂️
Currently sitting on 20k plus shares with substantial losses but I’ve known the potential of an exciting new market opportunity. The Telehealth outcome has been positive and they have a cost reduction plan. Clearly the sales force has not worked as well as other options so it makes sense to keep your better producing sales agents while leaning heavier on pathways that work more effectively from an outreach and cost perspective. The reduction in expenses will extend the runway and lower the potential of shareholder liquidation while giving the product cycle time to mature.
Buyout could still be on the table in the future should the drug continue to be adopted and utilized.
Time will tell but I’m here and won’t sell
3 replies
